Filing Details
- Accession Number:
- 0001209191-22-042766
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-20 18:18:38
- Reporting Period:
- 2022-07-18
- Accepted Time:
- 2022-07-20 18:18:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1845337 | Day One Biopharmaceuticals Inc. | DAWN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1655962 | Ii N Charles York | 395 Oyster Point Blvd, Suite 217 South San Francisco CA 94080 | Coo, Cfo And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-18 | 2,500 | $20.00 | 331,365 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021.
Billionaire Hedge Funds
